Replies to post #5060 on CytoSorbents Corporation (CTSO)

[SABAI]

"These 5 things are very bad For CTSO" ..... Oh sure, and That's why You Holding over 6.7M shares of CTSO. did you take your meds already today? LoL .

[eColi]

I agree this shouldn't uplist until there is a breakeven EPS.

I hope that will happen before Q4 2015, but it will depend on product efficacy in Europe, India, the Middle East, and the rest of the world; the FDA approval should also put it over the top. We're not sure when that will happen, or if it could be fast tracked when the military determines its value. When will we hear about the results of that FDA trial? (re: the Air Force funded, 30 patient, randomized controlled human pilot study in the United States for trauma patients with rhabdomyolysis.)

Don't forget the DARPA funding: up to $3.8 million as part of its Dialysis-Like Therapeutics (DLT) program to develop the broad-spectrum, porous polymers capable of removing cytokines, toxins and certain biowarfare agents from whole blood, with $1.5 million in funding designated for the first of five years, based upon the achievement of pre-determined milestones. Since that started in 2012, I suppose this money could keep flowing through 2017.

As far as 50% QoQ: if this product can be used in every blood storage and medical facility on earth, I think manufacturing limitations will be a bigger problem of ramping up sales.

I am LONG CTSO (since 2007, when it was MSBT). I've bought at lows of .066 and I've sold at highs of .381, and I still maintain a position.